Gynaecological Surgery
Gynaecological surgery not only requires control of bleeding and oozing across broad surfaces, but also requires physicians to maintain fertility in many of their patients. Baxter’s haemostats and sealants aim to help patients heal quicker with fewer complications, while Baxter’s adhesion reduction agents aim to help address post-operative adhesions.
Each gynaecological procedure presents unique challenges that can cause complications for the healing process. Here are a few examples.
Hysterectomy
FLOSEAL, Baxter’s flowable haemostat, provides quicker haemostasis (2 minutes median time to haemostasis) that stops many different types of bleeds.1 It can be applied across several procedures on appropriate grades of bleedings (e.g. in hysterectomy).
Myomectomy
Bleeding during and/or after a myomectomy can lead to different kinds of complications such as a return to the operating room. TISSEEL, Baxter’s fibrin sealant, mimics a physiological clot for resorption in 10-14 days5, has a broad indication for haemostasis and with a wide range of drip and spray applicators may be applied across several procedures on appropriate grades of bleedings (e.g. in myomectomy).
Gynecologic Laparoscopy
COSEAL Surgical Sealant is a fully synthetic resorbable hydrogel, designed to provide a rapid intraoperative seal and to maintain adhesion protection during the critical postoperative period.3
ADEPT® Adhesion Reduction Solution is a non-viscous, colorless liquid that contains 4% icodextrin. The solution provides broad coverage, temporary tissue separation, and serves as an irrigant throughout surgery.4
Portfolio of Products
Prescribing Information:
 |
Ireland TISSEEL |
Suspected Adverse Reactions and any drug product quality complaints (including suspected defective medicines) should be reported to the Health Products Regulatory Authority (HPRA) using a Yellow Card obtained from the HPRA, via the online system (www.hpra.ie) or by telephone on 01-6764971.
Adverse Events relating to Baxter products can also be reported direct to Baxter Pharmacovigilance on +44 1635 206360, or by email to [email protected]
Any drug product quality complaints relating to Baxter products can be reported directly to the Baxter Country Quality Assurance Team on 01 2065500, or by email to [email protected]. Alternatively please report directly to your Baxter Representative, who will take the details and forward to the Baxter Country Quality Assurance Team.